Skip to main content
. 2021 Dec 23;27:1610013. doi: 10.3389/pore.2021.1610013

TABLE 1.

Summary for histological diagnosis, expression of MMR proteins and p53, and genomic profile in 36 cases.

Case no. Age Histological diagnosis MMR p53 MSI TMB SNV and delins mutations TCGA type
TP53 MLH1 PMS2 MSH2 MSH6 POLE POLD1 TERT
1 60 EC (G2) pro. wt Low High NSMP
2 54 EC (G1) pro. wt Low U-high p.Val63Met c.2389G>T p.Val411Leu POLEmut
EC (G2) Low U-high c.2389G>T p.Val411Leu
3 67 EC (G2) pro. wt Low Low NSMP
4 68 EC (G2) def. wt High High MMR-d
5 63 EC (G2) pro. wt Low Low NSMP
6 64 EC (G3) def. wt High High p.Arg202Cys MMR-d
7 59 EC (G2) def. wt High High p.Pro991Leu MMR-d
8 55 EC (G2) pro. wt Low Low NSMP
9 60 EC (G2) def. wt High High p.Phe22fs MMR-d
10 61 EC (G2) pro. wt Low Low NSMP
11 78 EC (G3) def. wt High U-high p.Arg175His p.Met491fs MMR-d
12 60 EC (G2) pro. wt Low Low NSMP
13 55 EC (G2) pro. mt Low U-high p.Arg213* p.Arg107Trp
p.Arg134Gln
p.Arg427Cys
p.Asp758Asn p.Arg298Gln
p.Lys632Arg
p.Glu641*
p.Glu995Lys
p.Pro286Ser
p.Val411Leu
p.Ser579Asn
c.*334C>T
POLEmut
14 65 EC (G2) gld.  pro. mt Low Low p.Arg273Cys p53mut
solid pro. mt Low Low
15 68 EC (G2) gld.  pro. wt Low Low c.903+2T>A NSMP
solid pro. wt Low High c.903+2T>A
16 55 EC (G3) pro. mt Low Low c.993+1G>T p53mut
17 73 EC (G2) gld.  pro. wt Low Low NSMP
solid pro. wt Low Low
18 53 EC (G2) gld.  def. wt High Low p.Glu613_Phe614del p.Arg678Trp MMR-d
solid def. wt High U-high p.Glu613_Phe614del c.3582+5C>T p.Arg678Trp
19 56 EC (G2) gld.  pro. wt Low U-high p.Glu483* p.Arg1201Gln
p.Glu1234*
p.Pro286Arg POLEmut
solid pro. wt Low U-high p.Glu483* p.Arg240Gln
p.Glu1322*
p.Pro286Arg
20 51 DC EC (G1) High High p.Asp289dup MMR-d
De def. wt High High p.Ser388Phe p.Asp289dup p.Ala288Val
21 57 DC EC (G3) def. wt High High p.Lys373fs p.Ala288Val
p.Trp371Cys
p.Arg481Gly
MMR-d
EC (G 1) High High p.Asn287fs p.Tyr581His p.Trp371Cys
De High High p.Lys373fs p.Ala69Thr p.Tyr581His p.Trp371Cys
22 71 DC EC (G1) High High p.Ser577Ser
p.Trp712*
MMR-d
De def. wt High High p.Ser577Ser
p.Trp712*
p.Asp1013fs
23 64 SC pro. mt Low Low p.Arg249Ser p53mut
24 67 SC pro. mt Low Low p.Gly245Ser
p.Leu43fs
p53mut
25 57 SC pro. mt Low Low p.Arg248Gln p53mut
26 63 SC Ad    pro. mt Low Low p.Ile255Ser p53mut
Spn Low Low p.Ile255Ser
27 72 SC def. mt High U-high p.Arg306* p.Arg352His
c.2466+4C>T
p53mut/ MMR-d
28 75 SC pro. mt Low Low p.Ser241Phe p53mut
29 70 SC pro. mt Low Low p.Gln144* p53mut
30 65 SC pro. mt Low Low c.817C>T p53mut
31 77 SC pro. mt Low Low p.Ala276Gly p53mut
32 80 CS pro. mt Low Low p.Asn239Ser p53mut
33 58 CS pro. mt Low Low p.Cys176Phe
c.706T>A
p53mut
34 63 CS Car pro. wt Low Low NSMP
Src Low Low
35 64 CS Car def. wt High High MMR-d
Src High High
36 63 LCNEC pro. mt Low Low p.Phe113Ser p53mut

EC, endometrioid carcinoma; gld., glandular part; solid, solid part; DC, dedifferentiated endometroid carcinoma; CS, carcinosarcoma; SC, serous carcinoma; LCNEC, large cell neuroendocrine carcinoma; De, dedifferentiated part; Ad, adenocarcinoma part; Car, carcinomatous part; Sar, sarcomatous part; Spn, spindle cell part; MMR, mismatch repair protein; MSI, macrisatellite instability; TMB, tumor mutation burden; CNA, copy number alteration; Amp, amplification; SNV, single nucleotide variant; U-high, ultra high; pro., proficient; def., deficient; wt, wild-type; mt, mutation; PLOEmut, POLE, mutation; MMR-d, MMR-deficient; NSMP, no specific molecular profile; p53mut, p53 mutation.